1. ATIM-10. A PHASE I/II CLINICAL TRIAL OF AUTOLOGOUS CMV-SPECIFIC CYTOTOXIC T CELLS (CMV-TC) FOR GLIOBLASTOMA: DOSE ESCALATION AND CORRELATIVE RESULTS. (5th November 2018) Authors: Penas-Prado, Marta; Weathers, Shiao-Pei; Zhou, Shouhao; Kamiya-Matsuoka, Carlos; O'Brien, Barbara; Loghin, Monica; Harrison, Rebecca; Pei, Be Lian; Ictech, Sandra; Hunter, Kathy; Yung, W K Alfred; de Groot, John; Shpall, Elizabeth J; Heimberger, Amy; Rezvani, Katy Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗